Alembic Pharmaceuticals announces USFDA Tentative Approval for Selexipag for Injection, 1,800 mcg/vial
Alembic is the sole first applicant to file an ANDA for Selexipag for Injection, 1,800 mcg/vial Bengaluru, 15th July 2024: Alembic Pharmaceuticals
Read More